The specificity of fatigue in primary biliary cirrhosis: Evaluation of a large clinic practice

Hepatology

Volumn 52, Issue 2, 2010, Pages 562-570

  Al Harthy, Nadya ^a   Kumagi, Teru ^a   Coltescu, Catalina ^a   Hirschfield, Gideon M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; COLESTYRAMINE; DIURETIC AGENT; PROTON PUMP INHIBITOR; RIFAMPICIN; SERTRALINE; THYROXINE; URSODEOXYCHOLIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BRONCHITIS; CLINICAL PRACTICE; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; SCLERODERMA; SCORING SYSTEM; VARICOSIS;

FATIGUE; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77955703311     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23683     Document Type: Article

References (33)

1. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. HEPATOLOGY 2009;50:291-308.
2. Selmi C, Gershwin ME, Lindor KD, Worman HJ, Gold EB, Watnik M, et al. Quality of life and everyday activities in patients with primary biliary cirrhosis. HEPATOLOGY 2007;46:1836-1843.
3. Witt-Sullivan H, Heathcote J, Cauch K, Blendis L, Ghent C, Katz A, et al. The demography of primary biliary cirrhosis in Ontario, Canada. HEPATOLOGY 1990;12:98-105.
4. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-710.
5. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95:760-767.
6. Goldblatt J, Taylor PJ, Lipman T, Prince MI, Baragiotta A, Bassendine MF, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002;122:1235-1241.
7. Poupon RE, Chretien Y, Chazouilleres O, Poupon R, Chwalow J. Quality of life in patients with primary biliary cirrhosis. HEPATOLOGY 2004;40:489-494.
8. Björnsson E, Kalaitzakis E, Neuhauser M, Enders F, Maetzel H, Chapman RW, et al. Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up. Liver Int 2010;30:251-258.
9. Jones EA. Fatigue complicating chronic liver disease. Metab Brain Dis 2004;19:421-429.
10. Stanca CM, Bach N, Krause C, Tandon N, Freni MA, Gutierrez JA, et al. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol 2005;100:1104-1109.
11. Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2005;17:351-357.
12. Biagini MR, Tozzi A, Milani S, Grippo A, Amantini A, Capanni M, et al. Fatigue in primary biliary cirrhosis: a possible role of comorbidities. Eur J Gastroenterol Hepatol 2008;20:122-126.
13. Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2004;39:961-968. (Pubitemid 39388460)
14. Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, et al. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008;57:807-813.
15. Swain MG, Le T. Chronic cholestasis in rats induces anhedonia and a loss of social interest. HEPATOLOGY 1998;28:6-10.
16. Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004;53:587-592.
17. Kerfoot SM, D'Mello C, Nguyen H, Ajuebor MN, Kubes P, Le T, et al. TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice. HEPATOLOGY 2006;43:154-162.
18. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. HEPATOLOGY 2006;44:91-98.
19. Newton JL, Allen J, Kerr S, Jones DE. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int 2006;26:197-202.
20. Newton JL, Davidson A, Kerr S, Bhala N, Pairman J, Burt J, et al. Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol 2007;19:125-132. (Pubitemid 46204329)
21. Newton JL, Hudson M, Tachtatzis P, Sutcliffe K, Pairman J, Burt JA, et al. Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. HEPATOLOGY 2007;45:1496-1505. (Pubitemid 46918334)
22. Hollingsworth KG, Newton JL, Taylor R, McDonald C, Palmer JM, Blamire AM, et al. Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis. Clin Gastroenterol Hepatol 2008;6:1041-1048.
23. Newton JL, Bhala N, Burt J, Jones DE. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol 2006;44:776-783.
24. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. HEPATOLOGY 2005;42:1194-1202.
25. Prince MI, James OF, Holland NP, Jones DE. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000;32:368-373.
26. Jacoby A, Rannard A, Buck D, Bhala N, Newton JL, James OF, et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut 2005;54:1622-1629.
27. Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis: UDCA-PBC Study Group. N Engl J Med 1991;324:1548-1554.
28. Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006;130:715-720.
29. Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. HEPATOLOGY 2008;48:871-877.
30. Kumagi T, Abdalian R, Guindi M, Heathcote EJ. Progression in PBC: new insights from follow-up liver biopsies 10 years after diagnosis. HEPATOLOGY 2008;48:344A.
31. Newton J, Poyner E, Jones DE. Serum anti-mitochondrial antibodies and fatigue in primary biliary cirrhosis [letter]. Liver Int 2009;29:1285-1286.
32. Jones DE, Bhala N, Burt J, Goldblatt J, Prince M, Newton JL. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut 2006;55:536-541.
33. Newton JL, Pairman J, Sutcliffe K, Wilton K, Jones DE. A predictive model for fatigue and its etiologic associations in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2008;6:228-233.